A Buoyant Market
If you overlaid Tuesday's stock-market action upon the most recent deficit talks in Washington, you would get some pretty radical conclusions that all revolve around an imminent deal.
First, you would say Medicare will be left alone. That's because the easiest way to save on these costs is to negotiate at arms-length with the drug companies over pricing, and the strongest stocks in the healthcare segment are the big pharmaceutical players -- in addition to Gilead (GILD) and Celgene (CELG), which do have big government pay exposure. Those big pharma players had been stalling out of late, perhaps over fears of a tougher Medicare posture....668 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.